Research News and Research

RSS

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Nextrials, Inc., a leader in clinical research software and services, today announced that its electronic data capture (EDC) and clinical trial data management platform, Prism™, is now integrated with the study design tools offered by Formedix. Formedix's industry leading Origin™ products include database design tools based on the data standards developed by the Clinical Data Interchange Standards Consortium (CDISC), a platform that Nextrials fully supports.

10 Jun 2010

Researchers develop new computer program for early diagnosis of Alzheimer's disease

Researchers of the University of Granada have developed a new computer program that allows early diagnosis of Alzheimer's disease through processed images. This new system has enhanced successful early diagnosis of Alzheimer's disease up to 90%, which is an important progress within this area of study.

10 Jun 2010

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

StemCells, Inc. announced today that newly published independent research demonstrates that its GS2-M cell culture media formulation enhances the pluripotency of human embryonic stem and induced pluripotent stem cells. The Company's GS2-M medium has already been shown to enable the derivation and long-term maintenance of mouse iPS cells.

10 Jun 2010

Elsevier announces acquisition of Collexis

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.

10 Jun 2010

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that several of its experts will present on important industry issues at the Drug Information Association (DIA) 46th Annual Meeting, being held from June 13 – 17, 2010 in Washington, DC.

From Parexel 10 Jun 2010

NanoString Technologies launches new solution to detect CNVs in human genomic samples

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the launch of its early access program for a unique new solution that detects copy number variation in human genomic samples. The program was announced in conjunction with the company's participation in the European Human Genetics Conference in Gothenburg, Sweden.

From NanoString Technologies 10 Jun 2010

Nativis awarded patents in Japan, China, India for drug signal technology

Nativis, Inc., a La Jolla, Calif.-based life science company, has been issued patents in Japan, China and India for its innovative technology that captures the unique signals of approved drugs at the atomic level and then delivers the signal in a solution to treat serious illnesses. The technology, which also has U.S., Canadian and Australian patents, promises to transform the treatment of diseases, including those for which there are no known cures, such as brain cancer.

10 Jun 2010

Neutralizing inhibitory molecules does not improve regeneration in damaged spinal axons

Neuroscientists at the University of California, San Diego School of Medicine have found that removing three key inhibitory molecules from myelin - the insulating material that surrounds nerve cell fibers - does not significantly boost the ability of injured spinal axons to regenerate and restore themselves to full function.

10 Jun 2010

Scientists develop plastic antibody that works in bloodstream of living animal

Scientists are reporting the first evidence that a plastic antibody - an artificial version of the proteins produced by the body's immune system to recognize and fight infections and foreign substances - works in the bloodstream of a living animal. The discovery, they suggest in a report in the Journal of the American Chemical Society, is an advance toward medical use of simple plastic particles custom tailored to fight an array of troublesome "antigens."

10 Jun 2010

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

MAP Pharmaceuticals, Inc. today announced that the Company will present new analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy. The post hoc analyses will be presented at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California.

10 Jun 2010

RealMed signs multi-year agreement with UHealth, University of Miami Health System and UM Miller School of Medicine

RealMed Corporation, a leading provider of web-based revenue cycle management solutions for healthcare providers, hospitals, and payers, today announced a multi-year agreement with UHealth, University of Miami Health System and the UM Miller School of Medicine, to provide secure, Internet-based processing of electronic claims transactions, real-time claims editing, automatic claims status and electronic remittance advice management.

10 Jun 2010

Spectranetics plans multi-center, randomized clinical trial program for in-stent restenosis

The Spectranetics Corporation today announced its clinical trial plans related to the treatment of in-stent restenosis (ISR) in arteries above the knee, which remains a major unsolved medical problem. There is no device currently cleared or approved by the FDA to treat ISR.

10 Jun 2010

Researchers validate effectiveness of genome sequencing process for hereditary genetic diseases

A research team led by Dr. Nada Jabado at the MUHC Research Institute and Dr. Jacek Majewski at McGill University has proven for the first time that it is possible to identify any genetic disease in record time thanks to a powerful and reliable exome sequencing method. The exome, a small part of the genome ((less than) 2%), is of crucial interest with regard to research on genetic diseases as it accounts for 85% of mutations.

10 Jun 2010

2010 Independence Expo to promote active living and independence for aged and disabled Americans

United Spinal Association presents the 2010 Independence Expo – Long Island, the region's premier lifestyle-enhancing Expo designed to promote active living and independence for all people with disabilities and aging Americans.

10 Jun 2010

MicroConstants adds second Waters Xevo TQ MS system

MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, announces the continued expansion of its bioanalytical capacity through the addition of a second Waters Xevo TQ MS system. The CRO has also appointed a new East Coast business development manager to actively pursue new business opportunities in that region.

10 Jun 2010

Misinterpretation of genetic information may undermine efforts to promote behavioral changes for disease prevention

Does knowing that genes are partly responsible for your health condition mean you are less likely to be motivated to find out about the benefits of behavioral changes? According to Dr. Suzanne O'Neill from the National Human Genome Research Institute/National Institutes of Health, and her colleagues, people on the whole are still interested in how health habits affect disease risk.

10 Jun 2010

Pitchers who are morning types appear to have advantage over evening types: Study

A Major League Baseball pitcher's natural sleep preference might affect how he performs in day and night games, according to a research abstract that will be presented Wednesday, June 9, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

10 Jun 2010

Non-melanoma skin cancer is potential marker for survivors at risk for future malignant tumors

Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.

10 Jun 2010

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received grants totaling nearly $35 million in 2009.

10 Jun 2010

LAB Research completes development of novel drug investigation model

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that it has recently completed development of a novel drug investigation model focused on biodistribution and pharmacokinetic of biologics.

10 Jun 2010

Research News and Research

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Researchers develop new computer program for early diagnosis of Alzheimer's disease

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

Elsevier announces acquisition of Collexis

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

NanoString Technologies launches new solution to detect CNVs in human genomic samples

Nativis awarded patents in Japan, China, India for drug signal technology

Neutralizing inhibitory molecules does not improve regeneration in damaged spinal axons

Scientists develop plastic antibody that works in bloodstream of living animal

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

RealMed signs multi-year agreement with UHealth, University of Miami Health System and UM Miller School of Medicine

Spectranetics plans multi-center, randomized clinical trial program for in-stent restenosis

Researchers validate effectiveness of genome sequencing process for hereditary genetic diseases

2010 Independence Expo to promote active living and independence for aged and disabled Americans

MicroConstants adds second Waters Xevo TQ MS system

Misinterpretation of genetic information may undermine efforts to promote behavioral changes for disease prevention

Pitchers who are morning types appear to have advantage over evening types: Study

Non-melanoma skin cancer is potential marker for survivors at risk for future malignant tumors

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

LAB Research completes development of novel drug investigation model

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News